Group 1 - The company plans to acquire 100% equity of Guangzhou Jinnan Magnetic Materials Co., Ltd. through a combination of issuing shares and cash payment, while also raising supporting funds from no more than 35 specific investors [1][2] - This transaction is expected to constitute a related party transaction and a major asset restructuring, but it will not qualify as a restructuring listing [1] - As of the announcement date, the company has coordinated with intermediary institutions to conduct due diligence, and the auditing and evaluation work related to the transaction is ongoing [2][3] Group 2 - The company has disclosed its transaction plan and has resumed trading of its shares on April 28, 2025, after the relevant proposals were approved in a board meeting [2] - The company will continue to disclose progress on the transaction every thirty days until the shareholder meeting notice is issued [3]

证券代码：301323 证券简称：新莱福 公告编号：2025-033 广州新莱福新材料股份有限公司 关于发行股份及支付现金购买资产并 募集配套资金暨关联交易的进展公告 3、根据《上市公司重大资产重组管理办法》及《深圳证券交易所上市公司自律监管 指引第8号——重大资产重组》的有关规定，公司将根据本次交易进展情况及时履行信息 披露义务，在披露本次交易预案后但尚未发出审议本次交易相关事项的股东大会通知前， 每三十日发布一次本次交易的进展公告。 一、本次交易的基本情况 公司拟通过发行股份及支付现金的方式购买广州金南磁性材料有限公司（以下简称 "金南磁材"或"标的公司"）100%股权，并拟向不超过35名（含 35 名）特定投资者 发行股份募集配套资金（以下简称"本次交易"）。本次交易预计构成关联交易、重大 资产重组，但不构成重组上市。 二、本次交易的历史信息披露情况 1 1、公司因筹划本次交易事项，经申请，公司股票（证券简称：新莱福，证券代码： 301323）自2025年4月14日开市起停牌，停牌时间不超过10个交易日，具体内容详见公司 于2025年4月14日披露的《关于筹划发行股份及支付现金购买资产并募集配套资金暨关 ...

证券研究报告 并购重组跟踪（二十六） 证券分析师：陈刚 执业证书编号：S0600523040001 邮箱：cheng@dwzq.com.cn 研究助理：孔思迈 执业证书编号：S0600124070019 邮箱：kongsm@dwzq.com.cn 2025年7月7日 注：本报告所涉及个股/公司仅代表与产业或交易热点有关联，所引述资讯/数据/观点仅以展示为目的，不构成投资建议，个股层面请参照东吴证券研究所各行业组所推荐标的。 目录 1、本期并购动态回顾 2、风险提示 2 注：本报告所涉及个股/公司仅代表与产业或交易热点有关联，所引述资讯/数据/观点仅以展示为目的，不构成投资建议，个股层面请参照东吴证券研究所各行业组所推荐标的。 1. 本期并购动态回顾 注：本期为6.23-7.6，（如无特殊说明）后文同 3 注：本报告所涉及个股/公司仅代表与产业或交易热点有关联，所引述资讯/数据/观点仅以展示为目的，不构成投资建议，个股层面请参照东吴证券研究所各行业组所推荐标的。 一：政策更新 ✓ 7月4日，国务院国资委印发《关于新时代中央企业高质量推进品牌建设的意见》，提出注重并购重组企 业优质品牌资产的继承维护，形成整体优势 ...

证券代码：301323 证券简称：新莱福 公告编号：2025-032 广州新莱福新材料股份有限公司 关于发行股份及支付现金购买资产并 募集配套资金暨关联交易的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 特别提示： 1 301323）自2025年4月14日开市起停牌，停牌时间不超过10个交易日，具体内容详见公司 于2025年4月14日披露的《关于筹划发行股份及支付现金购买资产并募集配套资金暨关 联交易事项的停牌公告》（公告编号：2025-006）和2025年4月21日披露的《关于筹划发 行股份及支付现金购买资产并募集配套资金暨关联交易事项的停牌进展公告》（公告编 号：2025-007）。 2、公司于2025年4月25日召开第二届董事会第十一次会议和第二届监事会第十次 会议，会议审议通过了《关于公司发行股份及支付现金购买资产并募集配套资金暨关 联交易方案的议案》等相关议案，并于2025年4月28日在巨潮资讯网披露了《广州新莱 福新材料股份有限公司发行股份及支付现金购买资产并募集配套资金暨关联交易预案》 等相关公告。同时，经申请，公司股票（证券简称： ...

Group 1 - Beixin Road and Bridge's application for issuing shares to specific targets has been approved by the Shenzhen Stock Exchange, pending approval from the China Securities Regulatory Commission [1] - Wangbian Electric's shareholders plan to reduce their holdings by a total of up to 2.99% of the company's shares, with specific reductions detailed for each shareholder [1] - Guotou Zhonglu is planning a major asset restructuring, leading to a suspension of its stock trading for up to 10 trading days [2] Group 2 - Baiotai has signed a licensing agreement with SteinCares for the commercialization of BAT2406 in Brazil and Latin America, with total payments potentially reaching up to $10 million [3] - Dongfang Bio has obtained two medical device registration certificates for its products, which are valid until June 1, 2030 [4] - Pulaike's subsidiary has received a new veterinary drug registration certificate [5] Group 3 - Wanyi Technology has signed an agreement to establish a joint laboratory with the Energy Research Institute, with a total research and development budget of 6 million yuan [6] - Yingboer plans to use up to 300 million yuan of idle funds for financial management [7] - Blue Biological has received two new veterinary drug registration certificates [8] Group 4 - Jinkai New Energy intends to inject up to 1.247 billion yuan into its wholly-owned subsidiary to enhance its operational capabilities [9] - China Pacific Insurance's assistant general manager's qualification has been approved [10] - Zhaoyan New Drug is reducing its registered capital and notifying creditors [11] Group 5 - Weili Medical plans to invest 37.5 million yuan in establishing a medical industry investment fund [12] - Hongbai New Materials has signed a deposit agreement for idle raised funds [13] - Tongyou Technology is applying for a credit limit of 10 million yuan from a bank [14] Group 6 - Warner Pharmaceutical's subsidiary has received approval for its magnesium sulfate raw material drug [15] - Fuda Co. plans to establish a wholly-owned subsidiary with a capital contribution of 475 million yuan [16] - Yabao Pharmaceutical has obtained a loan commitment letter for stock repurchase of up to 90 million yuan [17] Group 7 - Zhongyin Securities' chairman has resigned due to work adjustments [18] - Aili Home has terminated its share reduction plan ahead of schedule [19] - Samsung New Materials has appointed a new financial officer [20] Group 8 - Guobang Pharmaceutical's subsidiary has received EU GMP certification for its product [21] - Yipin Hong has received a drug registration certificate for its injection solution [22] - Wenzhou Hongfeng's subsidiary has obtained a utility model patent certificate [23] Group 9 - Cangge Mining plans to sign a financial service agreement with Zijin Mining Group [24] - Naipu Mining's application for convertible bonds has been accepted by the Shenzhen Stock Exchange [25] - Shenyang Machine Tool has completed its major asset restructuring [26] Group 10 - Xinlaifu plans to distribute a cash dividend of 5 yuan per 10 shares [27] - Jiashitang plans to distribute a cash dividend of 1.7 yuan per 10 shares [28] - Manbuer plans to distribute a cash dividend of 2.5 yuan per 10 shares [29] Group 11 - Guo Wang Yingda plans to distribute a cash dividend of 0.51 yuan per 10 shares [30] - Changsha Bank's shareholder plans to reduce holdings by up to 0.92% [31] - Hu Nong Commercial Bank plans to distribute a cash dividend of 1.93 yuan per 10 shares [32] Group 12 - Huaxiang Co. plans to distribute a cash dividend of 1.17 yuan per 10 shares [33]

Group 1 - The core point of the announcement is the 2024 annual profit distribution plan, which was approved at the shareholders' meeting on May 15, 2025, where the company will distribute a cash dividend of RMB 5.00 for every 10 shares held, without issuing new shares or increasing capital reserves [2][4] - The total number of shares eligible for the dividend distribution is calculated based on the total share capital of 104,922,890 shares, excluding 1,398,790 shares that have been repurchased [1][2] - The cash dividend distribution will be executed on June 27, 2025, with the record date set for June 26, 2025, and the cash dividends will be directly credited to shareholders' accounts through their custodial securities companies [3][4] Group 2 - The cash dividend amount per share is calculated as 51,762,050 RMB divided by 104,922,890 shares, resulting in approximately 0.4933342 RMB per share [1][3] - The company will not withhold personal income tax for shareholders during the distribution, but tax will be calculated based on the holding period when shares are sold [2][3] - The reference price for the ex-dividend date will be adjusted by subtracting the cash dividend amount from the closing price on the record date [3][4]

本公司及全体董事会成员信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 特别提示： 031 广州新莱福新材料股份有限公司 2024年年度权益分派实施公告 证券代码：301323 证券简称：新莱福 公告编号：2025- 3、本次实施的分配方案与股东大会审议通过的分配方案及调整原则是一致的。 4、本次权益分派方案的实施距离股东大会通过权益分派方案的时间未超过两个月。 二、权益分派方案 本公司 2024 年年度权益分派方案为：以公司现有总股本剔除已回购股份 1,398,790 股 后的 103,524,100 股为基数，向全体股东每 10 股派 5.000000 元人民币现金（含税；扣税 后，境外机构（含 QFII、RQFII）以及持有首发前限售股的个人和证券投资基金每 10 股派 4.500000 元；持有首发后限售股、股权激励限售股及无限售流通股的个人股息红利税实行 差别化税率征收，本公司暂不扣缴个人所得税，待个人转让股票时，根据其持股期限计算 应纳税额【注】；持有首发后限售股、股权激励限售股及无限售流通股的证券投资基金所 涉红利税，对香港投资者持有基金份额部分按 10%征收，对内地投资 ...

暗盘资金正涌入这些股票，点击速看>>> 磁性材料板块短线走低，新莱福（301323）、宁波韵升（600366）、大地熊、中科磁业（301141）、正 海磁材（300224）等走低。 ...

Group 1 - The nuclear pollution prevention concept has seen a rebound, with companies like Jieqiang Equipment and Beihua Co. achieving two consecutive trading limit increases [1] - Rich Intelligence has experienced a rise of over 10%, while companies such as Hujiang Materials, CGN Technology, Puni Testing, and New Life have also shown significant gains [1] - The Israeli Defense Forces issued a warning on June 15, advising all personnel near Iranian nuclear reactors and weapon facilities to evacuate the area immediately [1]

Core Viewpoint - The A-share metal new materials sector is experiencing a significant rise, with notable increases in stock prices for various companies [1] Company Performance - In particular, Instech has surged nearly 14% [1] - Zhongzhou Special Materials, Jiangnan New Materials, and Tianli Composite have all risen over 8% [1] - Other companies such as Ningbo Yunsheng, Xinlai Fu, and Shenzhen New Star have also seen upward movement in their stock prices [1]